文献速递心境障碍精神分裂症与精神病性障碍

细胞全基因组关联研究识别影响锂诱导神经祖细胞增殖的常见遗传变异

Cellular Genome-wide Association Study Identifies Common Genetic Variation Influencing Lithium-Induced Neural Progenitor Proliferation.
PubMed 文献 · Biol Psychiatry · 2022-08-22

该研究利用80株已基因分型的人神经祖细胞系,通过EdU掺入实验和全基因组关联分析,发现chr3p21.1位点与锂诱导的神经祖细胞增殖相关,该位点也与双相障碍、精神分裂症风险及智力个体差异相关。GNL3基因表达在锂处理后呈等位基因特异性时间性升高,实验上调GNL3增加基线增殖,下调GNL3抑制锂诱导的增殖。结果表明常见遗传变异调控锂诱导的神经祖细胞增殖,GNL3表达是锂完全促增殖效应所必需。

要点

  • chr3p21.1位点与锂诱导的神经祖细胞增殖相关,同时与双相障碍和精神分裂症风险相关。
  • GNL3表达在锂处理后等位基因特异性升高,是锂促增殖效应所必需。
  • 在遗传多样性人细胞系中进行全基因组关联可发现情境特异性药物基因组效应。

核心结论

  • 常见遗传变异调控锂诱导的神经祖细胞增殖,GNL3表达是锂完全促增殖效应所必需。
  • 在遗传多样性人细胞系中进行全基因组关联是发现情境特异性药物基因组效应的有用方法。

研究设计与样本

  • 在80株已基因分型的人神经祖细胞系中进行EdU掺入实验,细胞经锂处理。
  • 利用上述数据进行全基因组关联分析,识别影响锂诱导神经祖细胞增殖的常见遗传变异。
  • 使用CRISPRi/a构建体操纵候选因果基因表达,实验验证锂诱导的增殖效应。

主要发现

  • 识别出chr3p21.1位点与锂诱导的增殖相关,该位点也与双相障碍风险、精神分裂症风险及智力个体差异相关。
  • 识别出单个基因GNL3,其表达在锂处理后呈等位基因特异性时间性升高。
  • 实验性增加GNL3表达导致基线条件下增殖增加,实验性降低GNL3表达抑制锂诱导的增殖。

临床怎么用

  • GNL3表达水平可能作为锂诱导神经祖细胞增殖效应的潜在药效学标志物。
  • chr3p21.1位点变异信息或有助于理解锂治疗反应的个体差异,但尚需临床验证。

局限性

  • 研究仅使用80株人神经祖细胞系,样本量有限。
  • 实验为体外细胞模型,未能反映体内复杂环境及临床治疗结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bipolar disorder is a highly heritable neuropsychiatric condition affecting more than 1% of the human population. Lithium salts are commonly prescribed as a mood stabilizer for individuals with bipolar disorder. Lithium is clinically effective in approximately half of treated individuals, and their genetic backgrounds are known to influence treatment outcomes. While the mechanism of lithium's therapeutic action is unclear, it stimulates adult neural progenitor cell proliferation, similar to some antidepressant drugs. METHODS: To identify common genetic variants that modulate lithium-induced proliferation, we conducted an EdU incorporation assay in a library of 80 genotyped human neural progenitor cells treated with lithium. These data were used to perform a genome-wide association study to identify common genetic variants that influence lithium-induced neural progenitor cell proliferation. We manipulated the expression of a putatively causal gene using CRISPRi/a (clustered regularly interspaced short palindromic repeats interference/activation) constructs to experimentally verify lithium-induced proliferation effects. RESULTS: We identified a locus on chr3p21.1 associated with lithium-induced proliferation. This locus is also associated with bipolar disorder risk, schizophrenia risk, and interindividual differences in intelligence. We identified a single gene, GNL3, whose expression temporally increased in an allele-specific fashion following lithium treatment. Experimentally increasing the expression of GNL3 led to increased proliferation under baseline conditions, while experimentally decreasing GNL3 expression suppressed lithium-induced proliferation. CONCLUSIONS: Our experiments reveal that common genetic variation modulates lithium-induced neural progenitor proliferation and that GNL3 expression is necessary for the full proliferation-stimulating effects of lithium. These results suggest that performing genome-wide associations in genetically diverse human cell lines is a useful approach to discover context-specific pharmacogenomic effects.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Wolter JM, Le BD, Matoba N, et al. Cellular Genome-wide Association Study Identifies Common Genetic Variation Influencing Lithium-Induced Neural Progenitor Proliferation. Biol Psychiatry. 2022. PMID: 36307327. doi:10.1016/j.biopsych.2022.08.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。